Takeda Pharmaceutical Company Limited Equity
Takeda Pharmaceutical Company Limited (TAK) had Equity of JPY 6.94 trillion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:Equity · last filed 2025-06-25
- 2025-03-31: Equity 6.94T JPY.
- 2024-03-31: Equity 7.27T JPY.
- 2023-03-31: Equity 6.35T JPY.
- 2022-03-31: Equity 5.69T JPY; Equity as first filed 5.68T JPY.
| Period end | Equity | Equity as first filed |
|---|---|---|
| 2025-03-31 | 6.94T JPY 20-F · filed 2025-06-25 | |
| 2024-03-31 | 7.27T JPY 20-F · filed 2025-06-25 | |
| 2023-03-31 | 6.35T JPY 20-F · filed 2025-06-25 | |
| 2022-03-31 | 5.69T JPY 20-F · filed 2025-06-25 | 5.68T JPY 20-F · filed 2022-06-29 |
| 2021-03-31 | 5.18T JPY 20-F · filed 2024-06-26 | |
| 2020-03-31 | 4.73T JPY 20-F · filed 2023-06-28 | |
| 2019-03-31 | 5.19T JPY 20-F · filed 2022-06-29 | 5.16T JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 2.02T JPY 20-F · filed 2021-06-29 | |
| 2017-03-31 | 1.95T JPY 20-F · filed 2020-06-24 | |
| 2016-03-31 | 2.01T JPY 20-F · filed 2019-06-27 |